Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with ...
Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...
Primerdesign (part of the Novacyt Group), a company focussed on the design, manufacture, validation and supply of real-time PCR kits and reagents, has signed a distribution agreement with Scientific ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
The transcription factor STAT3 is integral to the immune response during viral infections, while long non-coding RNAs (lncRNAs) are actively implicated in the modulation of viral pathogenesis. However ...
Abstract: To address the prevalent challenges of response latency and adaptability limitations in traditional unimodal control systems within dynamic complex environments, this study proposes a ...